ES2063156T3 - Nuevos derivados lisogangliosidos. - Google Patents

Nuevos derivados lisogangliosidos.

Info

Publication number
ES2063156T3
ES2063156T3 ES89403310T ES89403310T ES2063156T3 ES 2063156 T3 ES2063156 T3 ES 2063156T3 ES 89403310 T ES89403310 T ES 89403310T ES 89403310 T ES89403310 T ES 89403310T ES 2063156 T3 ES2063156 T3 ES 2063156T3
Authority
ES
Spain
Prior art keywords
lisogangliosidos
new derivatives
acil
group
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89403310T
Other languages
English (en)
Inventor
Valle Francesco Della
Aurelio Romeo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fidia SpA
Original Assignee
Fidia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia SpA filed Critical Fidia SpA
Application granted granted Critical
Publication of ES2063156T3 publication Critical patent/ES2063156T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Psychology (AREA)
  • Genetics & Genomics (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

NUEVOS N-ACIL-LISOGANGLIOSIDOS OBTENIDOS DE GANGLIOSIDOS POR DESACILACION DEL GRUPO CERAMIDA, EN DONDE EL GRUPO ACILO SE DERIVA DE UN ACIDO ALIFATICO QUE TENGA DE 2 A 24 ATOMOS DE CARBONO, SUSTITUIDO POR UNO O MAS GRUPOS POLARES. LOS N-ACIL-LISOGANGLIOSIDOS DE LA INVENCION PRESENTAN UNA ACCION INHIBIDORA DE LA ACTIVIDAD DE LA PROTEINA-QUINASA C, POR LO QUE PUEDEN UTILIZARSE EN TERAPIAS DE DIVERSAS PATOLOGIAS DEL SISTEMA NERVIOSO.
ES89403310T 1988-12-02 1989-11-29 Nuevos derivados lisogangliosidos. Expired - Lifetime ES2063156T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8848618A IT1235161B (it) 1988-12-02 1988-12-02 Derivati di lisogangliosidi

Publications (1)

Publication Number Publication Date
ES2063156T3 true ES2063156T3 (es) 1995-01-01

Family

ID=11267667

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89403310T Expired - Lifetime ES2063156T3 (es) 1988-12-02 1989-11-29 Nuevos derivados lisogangliosidos.

Country Status (15)

Country Link
EP (1) EP0373039B1 (es)
JP (1) JPH02200697A (es)
KR (1) KR910009721A (es)
AT (1) ATE103926T1 (es)
AU (1) AU630384B2 (es)
CA (1) CA2004189A1 (es)
DE (1) DE68914418T2 (es)
DK (1) DK589889A (es)
ES (1) ES2063156T3 (es)
FI (1) FI95577C (es)
HU (1) HU205129B (es)
IL (1) IL92513A0 (es)
IT (1) IT1235161B (es)
NO (1) NO173141C (es)
NZ (1) NZ231624A (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1235011B (it) * 1988-07-26 1992-06-16 Fidia Farmaceutici Sintesi di derivati di glicosfingolipidi ed in particolare di gangliosidi utilizzabili per la preparazione di immunoadsorbenti ed adsorbenti per affinita' impiegabili per la purificazione di anticorpi e di tossine specifiche, e per uso diagnostico
IT1232175B (it) * 1989-07-27 1992-01-25 Fidia Farmaceutici Analoghi semisintetici di gangliosidi
IT1232176B (it) * 1989-07-27 1992-01-25 Fidia Farmaceutici Derivati di-lisogangliosidi
IT1238346B (it) * 1989-11-14 1993-07-13 Gangliosidi modificati e loro derivati funzionali.
IT1239060B (it) * 1990-05-04 1993-09-20 Fidia Spa Processo per la modulazione selettiva dell'espressione e della funzione di un determinante sulla superficie cellulare attraverso appropriati agenti chimici
IT1253832B (it) * 1991-08-01 1995-08-29 Fidia Spa Derivati di gangliosidi
IT1254280B (it) * 1992-03-13 1995-09-14 Fidia Spa Composizioni farmaceutiche comprendenti monosialoganglioside gm1 o un suo derivato atte al trattamento della malattia di parkinson
WO2011026216A1 (en) * 2009-09-04 2011-03-10 The Governors Of The University Of Alberta Neuroprotective ganglioside compositions for use in treating or diagnosing huntington's disease
EP2420486B1 (en) * 2010-07-23 2013-11-06 Henkel Ireland Limited Method for producing 2-cyanoacetic acid anhydride and further reaction products thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
IT1182209B (it) * 1985-02-18 1987-09-30 Fidia Farmaceutici Uso terapeutico del monosialoganglioside gm1 e dei suoi derivati in gravi patologie di infarti cerebrali
NZ222192A (en) * 1986-10-20 1991-03-26 Kanto Ishi Pharma Co Ltd Glycolipid containing n-glycolylneuraminic acid, and preparation thereof
IT1235011B (it) * 1988-07-26 1992-06-16 Fidia Farmaceutici Sintesi di derivati di glicosfingolipidi ed in particolare di gangliosidi utilizzabili per la preparazione di immunoadsorbenti ed adsorbenti per affinita' impiegabili per la purificazione di anticorpi e di tossine specifiche, e per uso diagnostico
GB8827967D0 (en) * 1988-11-30 1989-01-05 Ward I M Die-free drawing
IN171530B (es) * 1989-11-17 1992-11-07 Fidia Spa

Also Published As

Publication number Publication date
IL92513A0 (en) 1990-08-31
JPH02200697A (ja) 1990-08-08
IT1235161B (it) 1992-06-22
AU630384B2 (en) 1992-10-29
FI95577B (fi) 1995-11-15
DE68914418T2 (de) 1994-10-06
HUT53116A (en) 1990-09-28
HU205129B (en) 1992-03-30
IT8848618A0 (it) 1988-12-02
AU4571889A (en) 1990-06-07
ATE103926T1 (de) 1994-04-15
EP0373039A3 (en) 1991-06-05
DK589889A (da) 1990-06-03
HU896337D0 (en) 1990-02-28
DK589889D0 (da) 1989-11-23
NO894820L (no) 1990-06-05
NO894820D0 (no) 1989-12-01
FI895765A0 (fi) 1989-12-01
EP0373039B1 (en) 1994-04-06
NO173141B (no) 1993-07-26
EP0373039A2 (en) 1990-06-13
NO173141C (no) 1993-11-03
CA2004189A1 (en) 1990-06-02
FI95577C (fi) 1996-02-26
NZ231624A (en) 1992-03-26
KR910009721A (ko) 1991-06-28
DE68914418D1 (de) 1994-05-11

Similar Documents

Publication Publication Date Title
OA03370A (fr) Procédé de préparation de 19-nor-4,9(10)-stéroïdes.
ES2073396T3 (es) Nuevos derivados ciclicos del acido antranilico y procedimiento para su preparacion.
ES2014438B3 (es) Derivados del acido 2-fosfonobutano-1,2,4tricarboxilico, como agentes emulsivos.
AR241108A2 (es) Insecticidas piretroides, acidos ciclopropancarboxilicos y esteres intermediarios y sus precedimientos de preparacion
NO894820D0 (no) Nye lysogangliosid-derivater.
ES2038776T3 (es) Procedimiento de preparacion de derivados de la oxima del 1,2,5,6-tetrahidropiridin-3-carboxaldehido.
ES2054021T3 (es) Composiciones limpiadoras liquidas y procedimiento para su preparacion.
ES8504807A1 (es) Procedimiento para preparar nuevas 4-fenil-tetrahidrofurano (2, 3-c) piridinas
ES8307779A1 (es) "un derivado de la piperazina".
UA26443A (uk) Похідhі 20,21-диhоребурhамеhіhу, їх рацемати або оптичhі ізомери, або їх адитивhі солі з оргаhічhими кислотами, що мають hоотропhі та аhтидепресивhі властивості
BE599012A (fr) Procédé de préparation de 1,2-dicarboximides 1-aryl-cyclo-aliphatiques.
JPS5215492A (en) Ozone generator
ES2052483T1 (es) Nuevos derivados del 3,3,5-trimetilciclohexanol, su procedimiento de preparacion asi como las composiciones terapeuticas que los contienen.
BE605216A (fr) Procédé de préparation de 1,2,4-thiodiazoles.
BE602992A (fr) Procédé de préparation de 4,4'-dihydroxydiarylalcanes purs.
FR1250163A (fr) Procédé de préparation de sels d'acides sulfo-sulfiniques organiques ainsi que de sels d'acides disulfoniques organiques
ES456914A1 (es) Procedimiento para la preparacion de sal monopotasica del a-cido 1,2,5-tiadiazol-3,4-dicarboxilico.
JPS51118276A (en) Shelf administering system for warehouse
FR1343475A (fr) Procédé de préparation de dérivés de 1, 4-benzodiazéipne
BE608801A (fr) Procédé de préparation d'esters dithiophosphoriques.
BE607551A (fr) Procédé de préparation de nouveaux dérivés d'acide isophtalique.
FR1475445A (fr) Procédé de préparation de composés d'addition renfermant du brome actif
BE603413R (fr) Procédé de préparation de dihydroperoxydes organiques.
ES385700A2 (es) Procedimiento para la preparacion de nuevos acidos carboxi-licos heterociclicos.
FR1253512A (fr) Procédé de préparation de 16. 17-méthylène-20-céto-stéroïdes

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 373039

Country of ref document: ES